Journal of Pain and Symptom Management
Volume 25, Issue 1 , Pages 7-8 , January 2003

Re: Mirtazapine in Cancer Patients

  • Arthur R Van Gool, MD

      Affiliations

    • Erasmus University Medical Center Rotterdam, The Netherlands
    • ,
  • Marjolein Bannink, MD

      Affiliations

    • Erasmus University Medical Center Rotterdam, The Netherlands
    • ,
  • Dirk L Stronks, MSc

      Affiliations

    • Erasmus University Medical Center Rotterdam, The Netherlands
    • ,
  • Martina S Vos, MD

      Affiliations

    • Bronovo Hospital The Hague, The Netherlands

References 

  1. Theobald DE, Kirsh KL, Holtsclaw E, et al.  An open-label, cross-over trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage. 2002;23(5):442–447

PII: S0885-3924(02)00595-X

Journal of Pain and Symptom Management
Volume 25, Issue 1 , Pages 7-8 , January 2003

Article Tools